Ophthalmology Times, Feb 1, 2006 - Ophthalmology Times

ADVERTISEMENT

Ophthalmology Times

ADVERTISEMENT

Ophthalmology Times, Feb 1, 2006
Pick a different issue
Feature Articles
Off-label bevacizumab shows promise for treating AMD
By Lynda Charters
Chicago—Off-label use of intravitreal bevacizumab (Avastin, Genentech) now holds promise for the treatment of neovascular age-related macular degeneration (AMD).
Could Indian ideas help crack China's cataract crunch?
By Jeffrey Parker
Setting aside decades of distrust, China's Premier Wen Jiabao hailed the vast potential for Sino-Indian cooperation in science and technology during a visit to technology export powerhouse Tata Consultancy Services in Bangalore.
Algorithmic formulations may help manage DME
By Lynda Charters
Chicago—Diabetic macular edema (DME), by its nature, is somewhat resistant to simple algorithmic treatment formulations because of the multifactorial nature of the decision-making process and the host of new therapies that continually become available, explained Julia Haller, MD.
Ophthalmic News
Allergan opens $60 million center
Irvine, CA—Allergan Inc. celebrated the opening of its new $60 million Herbert Research Center here in December. Touted as a state-of-the-art facility to study eye disease and neurologic disorders, the center will house areas for molecular biology, neuromodulator research, high-throughput screening, and medicinal chemistry.
ASC uses novel sedation techniques
Elmira, NY—An ambulatory surgery center (ASC) here has won an "Innovations in Quality Improvement Award" from the Accreditation Association for Ambulatory Health Care (AAAHC)'s Institute for Quality Improvement.
Review course targets practice administrators
San Francisco—The American Society of Ophthalmic Administrators (ASOA) will offer a day of Certified Ophthalmic Executive (COE) review courses on March 17, and a paper test on March 21, for ophthalmic administrators seeking to earn the COE credential.
Ruling: infringement of AMO found 'willful'
By Jennifer A. Webb
Fort Worth, TX—Alcon Inc. is disputing a judge's finding that the company intentionally copied aspects of Advanced Medical Optics (AMO) Inc.'s Sovereign phacoemulsification machine and says it will appeal.
Senior vitreoretinal fellows gather
Chicago—Ninety North American vitreoretinal fellows in their final year of training attended the 6th Annual Retinal Fellows' Forum in January to review current treatments and meet other industry members.
Video Journal explores hot topics, techniques
Cincinnati—Robert H. Osher, MD, professor of ophthalmology at the University of Cincinnati and medical director emeritus of the Cincinnati Eye Institute, is celebrating 20 years of the Video Journal of Cataract and Refractive Surgery with two issues in 2006.
Conference on Aging supports vision research
Washington, DC—Delegates to the White House Conference on Aging supported the need for vision-care research and Medicare and Medicaid reform to deal with increased numbers of older Americans.
Optos picked as technology partner
Dunfermline, Scotland—Optos plc has been selected as one of 36 technology pioneers for 2006 by the World Economic Forum.
QLT repositions strategy for verteporfin, growth
Vancouver, Canada—QLT Inc. has outlined a new strategic plan that refocuses it on key programs in an effort to streamline the company and increase revenues.
Editorial
Another day, another miracle
By Peter J. McDonnell, MD
In case you have been so busy with your practice and other obligations that you missed it, two medical miracles (my opinion) have recently been reported. Each is only partially relevant to the practice of ophthalmology, but it seems to me that these are worth awareness.

ADVERTISEMENT

Practice ToolsPractice Tools
Coding Counselor
Coding Counselor

Simple and accurate ICD-9 code search. Start Here

Patient Education
Patient Education

Print customized patient education handouts. Start Here

Dermatology Diagnosis
Dermatology Diagnosis

Identify skin diseases by age, gender, location. Start Here

AHRQ Clinical Guidelines
AHRQ Clinical Guidelines

Objective findings on medical interventions. Start Here

ADVERTISEMENT



Click here